Myelodysplastic syndrome drugs market to reach $3.84 billion by 2030 at 9.6% cagr, driven by rising demand for personalized medicine and genomics-based treatment approaches.
Read More
Myelodysplastic syndrome (mds) drugs market to reach $5.56 billion by 2030 at 8.7% cagr, driven by increasing incidences of myeloid leukemia and rising research and development activities.
Read More
Myc proto oncogene protein market to reach $3.44 billion by 2030 at 12.6% cagr, driven by increasing number of clinical trials and rising prevalence of cancer globally.
Read More
Mutation detection kits in genome editing market to reach $2.1 billion by 2030 at 13.0% cagr, driven by rising prevalence of genetic disorders and need for precise genomic analysis.
Read More
Muscle relaxant drugs market to reach $7.43 billion by 2030 at 7.8% cagr, driven by increasing number of sports injuries and rising cases of musculoskeletal disorders.
Read More
Multivitamin Capsules And Tablets Market Growth Is Accelerating As Industry Transformation Continues
Multivitamin capsules and tablets market to reach $40.6 billion by 2030 at 6.2% cagr, driven by increasing health consciousness among individuals and demand for preventive nutrition.
Read More
Multivalent vaccines market to reach $14.28 billion by 2030 at 9.4% cagr, driven by rising incidences of infectious diseases and increasing focus on broad-spectrum immunization.
Read More
Multiple sclerosis treatment market to reach $33.02 billion by 2030 at 4.7% cagr, driven by growing prevalence of neurological disorders and rising demand for long-term disease management solutions.
Read More
Multiple sclerosis drugs market to reach $61.43 billion by 2030 at 13.0% cagr, driven by strong support from government and non-government organizations funding research and treatment programs.
Read More
Multiple myeloma drugs market to reach $31.61 billion by 2030 at 6.7% cagr, driven by increasing prevalence of hematological cancer and growing demand for effective targeted therapies.
Read More